Abstract
Purpose: We attempted to confirm recent findings of Kanemoto et al. that demonstrated a positive association (p < 0.017) between a polymorphism in the promoter region of the interleukin 1-β (IL- 1β) gene and the clinical phenotype of temporal lobe epilepsy with hippocampal sclerosis (TLE+HS). Methods: We determined the frequency of this polymorphism in a group of 61 TLE+HS patients of European ancestry and compared it with that found in 119 ethnically matched control subjects. Results: Analysis of genotype and allele frequencies showed no statistically significant difference in the distribution of the polymorphism between the two groups (p = 0.10). Conclusions: These data suggest that this IL-1β promoter polymorphism does not act as a strong susceptibility factor for TLE+HS in a population of individuals of European ancestry.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 782-784 |
| Number of pages | 3 |
| Journal | Epilepsia |
| Volume | 42 |
| Issue number | 6 |
| DOIs | |
| State | Published - 2001 |
| Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Neurology
- Clinical Neurology
Fingerprint
Dive into the research topics of 'Lack of association between an interleukin 1 beta (IL-1β gene variation and refractory temporal lobe epilepsy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver